Form 4: LifeStance Health Group Chief Medical Officer Reports Stock Transactions

Ujjwal Ramtekkar, Chief Medical Officer of LifeStance Health Group, reports acquisition and disposal of common stock and restricted stock units.

Summary

• Ujjwal Ramtekkar, the Chief Medical Officer of LifeStance Health Group, filed a Form 4 detailing changes in beneficial ownership.
• On March 6, 2025, Ramtekkar acquired 57,107 restricted stock units (RSUs) at a price of $0, bringing the total shares beneficially owned to 119,520.
• On March 7, 2025, Ramtekkar acquired 20,805 performance-based restricted stock units (PSUs) at a price of $0, increasing the total to 140,325 shares.
• Also on March 7, 2025, 6,544 shares were disposed of at $7.59 to cover tax withholding obligations, resulting in a final holding of 133,781 shares.
• The filing was signed by Ryan Pardo, Attorney-in-Fact, on March 10, 2025.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing primarily reports routine stock transactions related to compensation. The vesting of PSUs could be seen as slightly positive, but the tax withholding is a standard procedure.

Positives

• The vesting of PSUs indicates that performance targets were likely met, which could be seen as a positive signal.

Negatives

• The disposal of 6,544 shares to cover tax obligations, while standard, reduces the total number of shares held by the reporting person.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. They are closely watched by investors for signals about management's confidence in the company's prospects.

Stakeholder Impact

• Shareholders may be interested in the transactions of company insiders as an indicator of management's view of the company's value.

Key Dates